tricine has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decristoforo, C; Dietrich, H; Gabriel, M; Skvortsova, I; Virgolini, IJ; von Guggenberg, E | 1 |
| Bai, Y; Chang, Y; Chen, S; Li, Z; Teng, B | 1 |
2 other study(ies) available for tricine and Benign Neoplasms
| Article | Year |
|---|---|
99mTc-labelled HYNIC-minigastrin with reduced kidney uptake for targeting of CCK-2 receptor-positive tumours.
Topics: Animals; Carcinoma, Medullary; Cysteine; Edetic Acid; Gastrins; Gene Expression Regulation, Neoplastic; Glycine; Humans; Kidney; Liver; Neoplasms; Organotechnetium Compounds; Radionuclide Imaging; Rats; Receptor, Cholecystokinin B; Technetium; Thyroid Neoplasms; Tissue Distribution | 2007 |
Technetium-99m-labeling and synthesis of thymidine analogs: potential candidates for tumor imaging.
Topics: Chelating Agents; Edetic Acid; Glycine; Isotope Labeling; Ligands; Magnetic Resonance Imaging; Models, Chemical; Neoplasms; Radiopharmaceuticals; Technetium; Thymidine | 2007 |